Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001610618-24-000046
Filing Date
2024-04-23
Accepted
2024-04-22 17:42:07
Documents
5
Effectiveness Date
2024-04-23
Reference 429
333-270781

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. FORM S-8 cdtxs-82024x04x22.htm S-8 58773
2 CALCULATION OF FILING FEE TABLES exhibit1072024-04x22.htm EX-FILING FEES 20479
3 CONSENT OF INDEPENDENT PUBLIC ACCOUNTING FIRM exhibit512024-04x22.htm EX-5.1 11785
4 CONSENT OF COOLEY LLP exhibit2312024-04x22.htm EX-23.1 2063
5 GRAPHIC cooleylogo.jpg GRAPHIC 38052
  Complete submission text file 0001610618-24-000046.txt   145211
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278872 | Film No.: 24862217
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)